BioHealth News
Bethesda’s AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)
BETHESDA, Md., May 06, 2024 (GLOBE NEWSWIRE) -- AsclepiX Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging computational biology from Johns Hopkins to identify and…
Read More
Rockville’s GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced topline…
Read More
BioSolution Designs Announces Formation of BeatBio Subsidiary to Develop Complex Multigenic Cardiovascular Therapies
FREDERICK, MD, UNITED STATES, May 1, 2024 /EINPresswire.com/ -- BioSolution Designs is pleased to announce the formation of its first drug development subsidiary, BeatBio,…
Read More
ARPA-H Sprinting toward solutions for women’s health
The ARPA-H Sprint for Women’s Health is a funding opportunity to address critical unmet challenges in women’s health, championing transformative innovations and tackling health conditions that…
Read More
BISNOW: Maryland Life Sciences Seeks To Shift Away From ‘A World Of Office Parks’
May 2, 2024, Emily Wishingrad, Washington, D.C. Maryland’s life sciences market, one of the largest in the country, has a lot of things going…
Read More
BioSolution Designs & RoosterBio Announce Collaboration on Genetically Modified MSCs for Biotherapeutic Development
Frederick, MD, May 2, 2024 – BioSolution Designs (BSD), a biotechnology invention studio developing proprietary platforms for multigenic gene and cell therapies, today announced…
Read More
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
Venlo, the Netherlands, April 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the first quarter…
Read More
MedCityNews: An Oveview of the Nation’s Largest SEED Fund
Eligible small businesses may receive millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding…
Read More
Deloitte Acquires Gryphon Scientific Business to Expand Security, Science and Public Health Capabilities
Acquisition will strengthen Deloitte team with a complement of data-driven biosecurity detection, prevention and emergency response solutions ARLINGTON, Va., April 29, 2024 /PRNewswire/ -- Deloitte announced…
Read More
Pitchbook: The World’s Top Startup Cities
PitchBook’s VC Ecosystem Rankings compare global cities based on the size and maturity of their startup networks. The framework helps founders, operators and investors…
Read More
Venable Ranks Among American Lawyer Magazine’s Top 100 Firms
Washington, DC (April 17, 2024) – Venable LLP is pleased to announce that it has been named to American Lawyer magazine’s 2024 Am Law 100 list. The annual ranking…
Read More
AURP Wins Stage One of the U.S. Small Business Administration’s 2024 Growth Accelerator Fund Competition
AURP awarded $50,000 in prize money for equitable access to entrepreneurship WASHINGTON, DC, and TUCSON, AZ / ACCESSWIRE / April 24, 2024 / The U.S. Small…
Read More
Virginia Innovation Partnership Corporation (VIPC) Names Joe Benevento as President & CEO
Benevento to lead Virginia’s strategic authority that invests in startup companies, entrepreneurship ecosystems, university commercialization, innovation growth VIPC is well-positioned to lead Virginia in…
Read More
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
BETHESDA, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read More
United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
The first living recipient of a UThymoKidney, in conjunction with a heart pump implant, is recovering after a successful transplant This transplant builds on…
Read More